Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000950170-25-079676
Filing Date
2025-05-30
Accepted
2025-05-30 16:00:19
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G  
1 primary_doc.xml SCHEDULE 13G 14728
  Complete submission text file 0000950170-25-079676.txt   16647
Mailing Address 867 BOYLSTON STREET 5TH FLOOR, #1361 BOSTON MA 02116
Business Address 867 BOYLSTON STREET 5TH FLOOR, #1361 BOSTON MA 02116 617.310.6130
NORTH RUN CAPITAL, LP (Filed by) CIK: 0001212897 (see all company filings)

EIN.: 364504416 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G

Mailing Address 1 GREAT VALLEY PARKWAY, SUITE 24 MALVERN PA 19355
Business Address 1 GREAT VALLEY PARKWAY, SUITE 24 MALVERN PA 19355 484-320-2930
TELA Bio, Inc. (Subject) CIK: 0001561921 (see all company filings)

EIN.: 455320061 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G | Act: 34 | File No.: 005-91207 | Film No.: 251010645
SIC: 3841 Surgical & Medical Instruments & Apparatus
(CF Office: 08 Industrial Applications and Services)